Abstract
Purpose
There are known connections between emotions and psoriasis; however, we have not established a clear pathway for this association. This study aimed to explore correlates of difficulties in emotional regulation in patients with psoriasis and predict the influence of emotional regulation in psoriasis disability.
Method
Two hundred and twenty eight participants completed the Difficulties in Emotion Regulation Scale, Self-administered Psoriasis Area and Severity Index, Psoriasis Disability Index, and Brief Symptom Inventory. Spearman’s correlation and a hierarchical stepwise multiple regression were carried out to analyse associations.
Results
Results indicated that patients with the most recent diagnoses experienced greater difficulty in acting in accordance with goals (r = .16, p < .05) but lesser difficulty in engaging in goal-directed behaviour (r = −.15, p < .05). Those with greater satisfaction with treatment exhibited fewer difficulties in emotional regulation (r = −.23, p < .01). The patients who experienced greater difficulty in emotional regulation perceived greater psoriasis severity (r = .15, p < .05) and disability (r = .36, p < .05), reported more psychopathological symptoms (correlations between .46 and .56), and missed work/school more frequently (r = .24, p < .05). Impulse control proved to be the strongest predictor to psoriasis disability (β = .34).
Conclusion
The results highlighted the relationship between emotional regulation difficulty, disease characteristics, and psychological variables in psoriasis disability emphasizing the importance of including a broader approach in clinical management of psoriatic patients.
Similar content being viewed by others
References
Icen M, Crowson CS, McEvoy MT, Dann FJ, Gabriel SE, Maradit KH. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009;60(3):394–401. doi:10.1016/j.jaad.2008.10.062.
Branco M, Nogueira P, Conteiras T. Uma observação sobre a prevalência de algumas doenças crónicas em Portugal Continental. In: Saúde Md, editor. Lisboa: Observatório Nacional de Saúde. 2005
Galadari I, Sharif MO, Galadari H. Psoriasis: a fresh look. Clin Dermatol. 2005;23(5):491–502. doi:10.1016/j.clindermatol.2005.01.009.
Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol. 2005;152(5):861–7. doi:10.1111/j.1365-2133.2005.06502.x.
Gupta MA, Gupta AK. Current concepts in psychodermatology. Current Psychiatry Reports. 2014;16(6):449. doi:10.1007/s11920-014-0449-9.
Madhulika A, Gupta M. Psychodermatology. Psychiatric Times. 2006;23:78–89.
Janković S, Raznatović M, Marinkovic J, Maksimović N, Janković J, Djikanović B. Relevance of psychosomatic factors in psoriasis: a case-control study. Acta Derm Venereol. 2009;89(4):364–8.
Mazzetti M, Mozzetta A, Soavi GC, et al. Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol Suppl. 1994;186:62–4.
Zachariae R, Zachariae H, Blomqvist K, et al. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol. 2004;18(1):27–36.
Griffiths CEM, Richards HL. Psychological influences in psoriasis. Clin Exp Dermatol. 2001;26(4):338–42. doi:10.1046/j.1365-2230.2001.00834.x.
Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21(1):54–9. doi:10.1111/j.1529-8019.2008.00170.x.
Hrehorów E, Salomon J, Matusiak L, Reich A, Szepietowski C. Patients with psoriasis feel stigmatized. Acta Dermato Venereologica. 2011;91:1–6.
Gupta MA, Gupta AK, Kirkby S, et al. Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates. Arch Dermatol. 1988;124(7):1052–7.
Bhosle M, Kulkarni A, Feldman S, Balkrishnan R. Quality of life in patients with psoriasis. Health and Quality of Life Outcomes. 2006;4(1):35.
Fernandes BC. Qualidade de vida nos doentes com psoríase—Criação da versão Portuguesa do Psoriasis Disability Index. Coimbra: University of Coimbra; 2010.
Richards HL, Fortune DG, Griffiths CEM, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res. 2001;50(1):11–5.
Leibovici V, Canetti L, Yahalomi S, et al. Well being, psychopathology and coping strategies in psoriasis compared with atopic dermatitis: a controlled study. J Eur Acad Dermatol Venereol. 2010;24(8):897–903. doi:10.1111/j.1468-3083.2009.03542.x.
Russo PAJ, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol. 2004;45(3):155–61. doi:10.1111/j.1440-0960.2004.00078.x.
Mota SMC, Gon CCM, Gon SA. Análise comportamental de Problemas de Interação Social de Individuos com Psoríase. Interação em Psicologia. 2009;13(1):155–64.
Reich K, Nestle FO, Wu Y, et al. Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis. Eur J Dermatol. 2007;17(5):381–6.
Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139(5):846–50. doi:10.1046/j.1365-2133.1998.02511.x.
Rapp SR, Exum ML, Reboussin DM, Feldman SR, Fleischer A, Clark A. The physical, psychological and social impact of psoriasis. J Health Psychol. 1997;2(4):525–37. doi:10.1177/135910539700200409.
Gross JJ. Emotion regulation: affective, cognitive, and social consequences. Psychophysiology. 2002;39(3):281–91. doi:10.1017/s0048577201393198.
Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 2004;26(1):41–54.
Barankin B, DeKoven J. Psychosocial effect of common skin diseases. Can Fam Physician. 2002;48:712–6.
Fry L. An atlas of psoriasis. 2nd ed. London: Taylor & Francis Group; 2004.
Ramsay B, O’Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol. 1988;118(2):195–201. doi:10.1111/j.1365-2133.1988.tb01774.x.
Vardy D, Besser A, Amir M, Gesthalter B, Biton A, Buskila D. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002;147(4):736–42.
Chisholm A, Nelson PA, Pearce CJ, et al. The role of personal models in clinical management: exploring health care providers’ beliefs about psoriasis. Br J Health Psychol. 2016;21(1):114–34. doi:10.1111/bjhp.12148.
de Korte J, Sprangers MA, Mombers FM, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004;9(2):140–7.
Allegranti I, Gon T, Magatonrizzi G, Aguglia E. Prevalence of alexithymic characteristics in psoriatic patients. Acta Derm Venereol. 1994;74:146–7.
Mingnorance R, Loureiro S, Okino L, Foss N. Pacientes com psoríase: adaptação psicossocial e características de personalidade. Medicina. 2001;34:315–24.
Bahmer JA, Kuhl J, Bahmer FA. How do personality systems interact in patients with psoriasis, atopic dermatitis and urticaria? Acta Derm Venereol. 2007;87(4):317–24.
Schmutz JL. How to evaluate the severity of psoriasis? Ann Dermatol Venereol. 2003;130(8–9 Pt 2):843–6.
Feldman SR, Fleischer Jr AB, Reboussin DM, et al. The self-administered psoriasis area and severity index is valid and reliable. The Journal Of Investigative Dermatology. 1996;106(1):183–6.
Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol. 1990;123(6):751–6. doi:10.1111/j.1365-2133.1990.tb04192.x.
Simões M, Machado C, Gonçalves M, Almeida L. Avaliação psicológica: Instrumentos validados para a população portuguesa. Coimbra: Quarteto; 2007.
Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CEM. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol. 2001;45(1):72–6.
Ginsburg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol. 1993;32(8):587–91.
Devrimci-Ozguven H, Kundakci N, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14(4):267–71. doi:10.1046/j.1468-3083.2000.00085.x.
Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S. An Italian study on psoriasis and depression. Dermatology. 2006;212(2):123–7.
Aghaei S, Ardekani GS. Impact of psoriasis on quality of life in Iran. J Eur Acad Dermatol Venereol. 2007;21:32–3.
Castro SI, Rocha JC. The moderating effects of previous losses and emotional clarity on bereavement outcome. Journal of Loss and Trauma. 2012;18(3):248–59. doi:10.1080/15325024.2012.687327.
Coutinho J, Ribeiro E, Ferreirinha R, Dias P. The Portuguese version of the difficulties in emotion regulation scale and its relationship with psychopathological symptoms. Rev Psiquiatr Clín. 2009;37(4):145–51.
Finlay AY, Coles EC. The effect of severe psoriasis on the quality-of-life of 369 patients. Br J Dermatol. 1995;132(2):236–44.
DeWeerdt S. Psychodermatology: an emotional response. Nature. 2012;492(7429):S62–S3.
Fortune DG, Richards HL, Griffiths CE, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol. 2002;41(Pt 2):157–74.
Paradisi A, Abeni D, Finore E, et al. Effect of written emotional disclosure interventions in persons with psoriasis undergoing narrow band ultraviolet B phototherapy. Eur J Dermatol. 2010;20(5):599–605.
Fordham B, Griffiths CE, Bundy C. A pilot study examining mindfulness-based cognitive therapy in psoriasis. Psychol Health Med. 2015;20(1):121–7. doi:10.1080/13548506.2014.902483.
Schut C, Muhl S, Reinisch K, et al. Agreeableness and self-consciousness as predictors of induced scratching and itch in patients with psoriasis. Int J Behav Med. 2015;22(6):726–34. doi:10.1007/s12529-015-9471-5.
Chambers R, Gullone E, Allen NB. Mindful emotion regulation: an integrative review. Clin Psychol Rev. 2009;29(6):560–72. doi:10.1016/j.cpr.2009.06.005.
Acknowledgments
The authors would like to thank CESPU [project 04-GCQF-CICS-2011N] for their financial support, all patients who participated in the study, and the Portuguese Association of Psoriasis (PSOPortugal) for assistance with data collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Almeida, V., Taveira, S., Teixeira, M. et al. Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology Symptoms. Int.J. Behav. Med. 24, 563–570 (2017). https://doi.org/10.1007/s12529-016-9617-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12529-016-9617-0